Kevin Michael O'Neill - Mar 1, 2024 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, PDx
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
Mar 1, 2024
Transactions value $
-$750,778
Form type
4
Date filed
3/5/2024, 05:54 PM
Previous filing
Aug 7, 2023
Next filing
Aug 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Tax liability -$119K -1.31K -4.51% $91.28 27.7K Mar 1, 2024 Direct F1
transaction GEHC Common Stock, par value $0.01 per share Tax liability -$195K -2.14K -7.73% $91.28 25.6K Mar 1, 2024 Direct F1
transaction GEHC Common Stock, par value $0.01 per share Tax liability -$157K -1.72K -6.72% $91.28 23.8K Mar 1, 2024 Direct F1
transaction GEHC Common Stock, par value $0.01 per share Tax liability -$279K -3.06K -12.83% $91.28 20.8K Mar 1, 2024 Direct F2
transaction GEHC Common Stock, par value $0.01 per share Award $0 +3.24K +15.57% $0.00 24K Mar 1, 2024 Direct F3, F4
holding GEHC Common Stock, par value $0.01 per share 59 Mar 1, 2024 By share incentive plan trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award $0 +9.2K $0.00 9.2K Mar 1, 2024 Common Stock, par value $0.01 per share 9.2K $92.72 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F2 Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023.
F3 Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.
F4 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F5 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.